Skip to main content
    V

    Vivos Therapeutics Inc (VVOS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.08
    -0.02 (-16.12%)

    Market Cap: $3.29M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Vivos Therapeutics Inc (VVOS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Vivos Therapeutics are enVVeno Medical (NVNO), INVO Fertility (IVF) and Tenon Medical (TNON). By market cap, Vivos Therapeutics ranks 9th of the 13 companies on this page; Neuroone Medical Technologies (NMTC) is the largest at $6.78M.

    Peer Comparison

    VVOS's ROIC of -237.8% is below the peer median of -74.8%, and its revenue growth of 34.9% is above the median of 16.5%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Vivos Therapeutics (VVOS)$3.29MN/A0.1x-121.8%-237.8%34.9%0.00%
    enVVeno Medical Corp (NVNO)$4.29MN/AN/A0.0%N/A0.0%0.00%
    INVO Fertility, Inc. (IVF)$3.10MN/A0.2x-92.3%-36.1%16.7%0.00%
    Tenon Medical Inc (TNON)$3.79MN/A0.3x-257.9%N/A126.8%0.00%
    Beyond Air Inc (XAIR)$3.55MN/A0.5x0.0%-113.5%0.5%0.00%
    Nuwellis Inc (NUWE)$2.65MN/AN/A-125.6%N/A14.1%0.00%
    Trinity Biotech plc (TRIB)$4.96MN/AN/A-85.4%-14.3%-5.5%0.00%
    WORK Medical Technology Group LTD Ordinary Shares (WOK)$5.36MN/AN/A-41.9%-17.8%19.1%0.00%
    GlucoTrack Inc (GCTK)$2.43MN/AN/A0.0%-6319.2%0.0%0.00%
    Icecure Medical (ICCM)$3.39MN/A0.6x0.0%N/A72.8%0.00%
    Intelligent Bio Solutions Inc. (INBS)$5.84MN/A1.0x-269.3%N/A25.2%0.00%
    Neuroone Medical Technologies Corp (NMTC)$6.78MN/A0.7x-59.7%-147.0%16.3%0.00%
    Co-Diagnostics, Inc. Common Stock (CODX)$2.72MN/A1.6x0.0%N/A94.6%0.00%
    Peer median$3.67MN/A0.6x-50.8%-74.8%16.5%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Vivos Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Medical Devices.

    CompanyAboutPeers
    enVVeno Medical Corp (NVNO)
    enVVeno Medical Corp (NVNO) is a pioneering medical device firm focused on revolutionizing vascular access solutions for dialysis patients with its proprietary...
    NVNO competitors
    INVO Fertility, Inc. (IVF)
    INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients.
    IVF competitors
    Tenon Medical Inc (TNON)
    Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and outcomes.
    TNON competitors
    Beyond Air Inc (XAIR)
    Beyond Air, Inc., a clinical-stage biopharmaceutical and medical device company, develops nitric oxide (NO) generators and delivery systems.
    XAIR competitors
    Nuwellis Inc (NUWE)
    Nuwellis, Inc., a medical device company, focuses on the development, manufacture and marketing of medical devices used in ultrafiltration therapy.
    NUWE competitors
    Trinity Biotech plc (TRIB)
    Trinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments...
    TRIB competitors
    WORK Medical Technology Group LTD Ordinary Shares (WOK)
    WORK Medical Technology Group Ltd is a pioneering player in the medical technology sector, dedicated to the advancement of healthcare through the research...
    GlucoTrack Inc (GCTK)
    GlucoTrack, Inc., a medical device company, designs, develops and markets noninvasive glucose monitoring devices for people with diabetes and prediabetes...
    GCTK competitors
    Icecure Medical (ICCM)
    IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for the women's health and oncology markets.
    ICCM competitors
    Intelligent Bio Solutions Inc. (INBS)
    Intelligent Bio Solutions Inc. (INBS) is a pioneering biotechnology company focused on delivering cutting-edge diagnostic solutions and biomarker-driven...
    INBS competitors
    Neuroone Medical Technologies Corp (NMTC)
    NeuroOne Medical Technologies Corporation is a medical technology company. The company is headquartered in Eden Prairie, Minnesota.
    NMTC competitors
    Co-Diagnostics, Inc. Common Stock (CODX)
    Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and /...
    CODX competitors

    Frequently Asked Questions About VVOS

    Who are Vivos Therapeutics' main competitors?

    The companies most similar to Vivos Therapeutics include enVVeno Medical (NVNO), INVO Fertility (IVF), Tenon Medical (TNON), Beyond Air (XAIR) and Nuwellis (NUWE), listed from the closest match.

    Who is Vivos Therapeutics' biggest competitor?

    Neuroone Medical Technologies (NMTC) is the largest of the similar companies at $6.78M; enVVeno Medical (NVNO) is the closest match by business profile, size, sector and industry.

    How does VVOS stock compare with its competitors?

    VVOS' P/S is 0.1x against a peer median of 0.6x; its net margin is -121.8% against a peer median of -50.8%.

    Which of Vivos Therapeutics' competitors pays a higher dividend?

    Vivos Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Vivos Therapeutics bigger than its competitors?

    No. Vivos Therapeutics is 9th by market cap among the 13 companies on this page; the largest is Neuroone Medical Technologies (NMTC) at $6.78M.